Spain Contraceptive Devices Market Size
| Study Period | 2020 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Historical Data Period | 2020 - 2022 |
| CAGR | 7.90 % |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Spain Contraceptive Devices Market Analysis
The Spanish contraceptive device market is expected to register a 7.9% CAGR during the forecast period.
The COVID-19 pandemic had a significant impact on the contraceptive device market at first.The strict lockdowns and government regulations intended to slow down the spread of COVID-19 resulted in a decrease in access to contraceptive devices. Moreover, due to house confinement, sexual activities were notably reduced in the country. For instance, according to an article published by PubMed in May 2021, a survey was conducted on 1,407 women in Spain, and 53.5% of them responded that their sexual activity decreased during the pandemic. Furthermore, according to an article published by the Journal of Clinical Medicine in July 2022, the frequency of sexual relationships was reduced among women in Spain, and it was even lower in those who did not live with their partners during the pandemic. The article further stated that women in Spain faced difficulties accessing contraceptive methods during the pandemic, and these women belonged to the age group of 25 to 34 years. Thus, the COVID-19 outbreak affected the market's growth adversely in its preliminary phase; however, currently, the market has reverted back to the pre-pandemic phase, and it is expected to gain traction in the forecast period of the study.
Furthermore, the increasing prevalence of sexually transmitted diseases (STDs), increasing awareness about STDs, and rising government initiatives are among the major factors driving the growth of the studied market. Currently, people are extremely concerned about their sexual health, and awareness about the usage of contraceptive devices to prevent any STDs is increasing in the country. Such factors are likely to boost the adoption of contraceptive devices, thereby contributing to the studied market's growth. For instance, according to an article published by ScienceDirect in January 2022, the incidence of STDs in Spain has been growing in recent decades, and the number of gonococcal infections per 100,000 persons continues to increase every year in the country. Therefore, the increasing prevalence of STDs in the country will boost the adoption of contraceptive devices, and hence, the studied market is expected to experience growth in the future.
In addition, the rising initiatives by the government of Spain are positively affecting the growth of the studied market. For instance, according to the Council of Ministers of Spain in May 2022, the Government of Spain reformed the law regarding sexual and reproductive health and the voluntary interruption of pregnancy and took new measures on sexuality education and contraception, menstrual health, pregnancy, childbirth, abortion, and reproductive violenceres on sexuality education and contraception, menstrual health, pregnancy, childbirth, abortion, and reproductive violence. It was also mentioned that guaranteed access to barrier methods of contraception will be distributed free of charge in high schools, prisons, and social service centers, and that public funding is also to be expanded and priority given to the latest generation of contraceptives in Spain. Moreover, the development and research of male contraception will also be promoted to encourage men's co-responsibility.
Therefore, owing to the aforementioned factors, such as the increasing prevalence of sexually transmitted diseases (STDs), increasing awareness about STDs, and rising government initiatives, the studied market is anticipated to witness growth over the analysis period. However, the side effects associated with the use of contraceptive devices are likely to impede the market's growth.
Spain Contraceptive Devices Market Trends
Condom is Expected to Witness High Growth Over the Forecast Period
Condoms are thin, loose-fitting pouches or sheaths that fit in the genital areas, and they are considered barrier-based contraceptive devices that help in the prevention of sexually transmitted diseases (STDs), such as HIV and herpes. As a barrier method of birth control, condoms can stop the sperm cell from reaching eggs, thus preventing fertilization. Condoms can be used by both males and females. Hence, owing to the advantages offered by condoms, the adoption of these products is likely to increase among the target population, ultimately driving segment growth.
Moreover, according to an article published by BMC in November 2021, a national survey on contraception in Spain was conducted in 2020 among 1800 women between 15 and 49 years of age, and it was reported that condoms are the method most frequently used for contraceptive devices and that they are used by an estimated 31.3% of couples. The article further stated that condoms are a very good method of protection against sexually transmitted infections (STIs). Furthermore, according to the article published by Springer in January 2022, HIV is considered one of the greatest sexual risks for young people, and condom use is the best protective measure to prevent such infections. Hence, the increasing adaptability of condoms and the advantages offered by them in STD prevention are expected to boost the growth of the market.
Due to the above factors, the condom segment is expected to grow a lot over the next few years.
Intra Uterine Device (IUD) Segment is Expected to Have a Significant Share in the Market Over the Forecast Period
An intrauterine device, also known as an intrauterine contraceptive device or coil, is a small, often T-shaped birth control device that is inserted into the uterus to prevent pregnancy. IUDs help protect against pregnancy for 5 or 10 years, depending on the type. When an IUD is implanted, it begins working immediately.Most people with a womb can use it. There are no hormonal side effects, such as acne, headaches, or breast tenderness.
Factors such as increasing adoption of intrauterine devices, increasing awareness about birth control, and rising government initiatives are enhancing the growth of the market. For instance, according to an article published by PubMed in September 2022, a study showed that satisfaction with using levonorgestrel-releasing intrauterine systems (LNG-IUD) is high among Spanish women.
Therefore, due to the aforementioned factors, the intrauterine devices (IUD) segment is expected to experience growth during the forecast period of the study.
Spain Contraceptive Devices Industry Overview
Because there are so few companies operating in the region, the market for contraceptive devices in Spain is highly consolidated. The competitive landscape includes an analysis of a few international as well as local companies that hold market shares and are well known. Key companies include AbbVie (Allergan PLC), Bayer AG, Cooper Surgical Inc., Viatris, Inc. (Mylan Laboratories), Pfizer Inc., Teva Pharmaceutical Industries Ltd., CEX Internacional, S.A., GAUTEX MEDICA, and Reckitt Benckiser, among others.
Spain Contraceptive Devices Market Leaders
-
AbbVie (Allergan PLC)
-
Bayer AG
-
Cooper Surgical Inc.
-
Reckitt Benckiser
-
Teva Pharmaceutical Industries Ltd
*Disclaimer: Major Players sorted in no particular order
Spain Contraceptive Devices Market News
- October 2022: Bayer AG launched its Mirena intrauterine device (IUD) for extended duration of use in contraception in Europe after it received EU approval.
- May 2022: Perrigo Company plc completed the acquisition of HRA Pharma. HRA Pharma is a leading provider of intrauterine (IUD) devices, and it has a presence in Spain.
Spain Contraceptive Devices Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Deliverables
- 1.2 Study Assumptions
- 1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Increasing Prevalence of Sexually Transmitted Diseases and Rising Awareness About Them
- 4.2.2 Rise in Government Initiatives
-
4.3 Market Restraints
- 4.3.1 Side Effects Associated with the Use of Contraceptive Devices
-
4.4 Porter's Five Forces Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
-
5.1 By Type
- 5.1.1 Condoms
- 5.1.2 Diaphragms
- 5.1.3 Cervical Caps
- 5.1.4 Sponges
- 5.1.5 Vaginal Rings
- 5.1.6 Intra Uterine Device (IUD)
- 5.1.7 Other Product Types
-
5.2 By Gender
- 5.2.1 Male
- 5.2.2 Female
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 AbbVie (Allergan PLC)
- 6.1.2 Bayer AG
- 6.1.3 Cooper Surgical Inc.
- 6.1.4 Viatris, Inc. (Mylan Laboratories)
- 6.1.5 Pfizer Inc.
- 6.1.6 Teva Pharmaceutical Industries Ltd
- 6.1.7 CEX Internacional, S.A.
- 6.1.8 GAUTEX MEDICA
- 6.1.9 Reckitt Benckiser
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablitySpain Contraceptive Devices Industry Segmentation
As per the scope of the report, a contraceptive device is a device that prevents the entry of sperm into the uterus, and they are used for the intentional prevention of conception. The Spain Contraceptive Devices Market is expected to register a CAGR of 7.9% over the forecast period (2022-2027). The Spain contraceptive devices market is segmented by type (condoms, diaphragms, cervical caps, sponges, vaginal rings, intrauterine devices (IUD), and other types) and gender (male and female). The report offers the value (in USD million) for the above segments.
| By Type | Condoms |
| Diaphragms | |
| Cervical Caps | |
| Sponges | |
| Vaginal Rings | |
| Intra Uterine Device (IUD) | |
| Other Product Types | |
| By Gender | Male |
| Female |
Spain Contraceptive Devices Market Research FAQs
What is the current Spain Contraceptive Devices Market size?
The Spain Contraceptive Devices Market is projected to register a CAGR of 7.90% during the forecast period (2024-2029)
Who are the key players in Spain Contraceptive Devices Market?
AbbVie (Allergan PLC), Bayer AG, Cooper Surgical Inc., Reckitt Benckiser and Teva Pharmaceutical Industries Ltd are the major companies operating in the Spain Contraceptive Devices Market.
What years does this Spain Contraceptive Devices Market cover?
The report covers the Spain Contraceptive Devices Market historical market size for years: 2020, 2021, 2022 and 2023. The report also forecasts the Spain Contraceptive Devices Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Spain Contraceptive Devices Industry Report
Statistics for the 2024 Spain Contraceptive Devices market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Spain Contraceptive Devices analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
